Basic Information
Basic information for SNHG14-315-43aa-2
Peptide Name SNHG14-315-43aa-2
Genome Position chr15:25117482-25117515,25118271-25118365[+]
Species Human
Peptide Sequence MPTCGLLDTLADDFLGTLLGVNVISKFPKQHPLDKKPPHLCIA
Peptide Length 43
Unique No (SNHG14-236-43aa,SNHG14-248-43aa,SNHG14-263-43aa-2,SNHG14-272-43aa-1,SNHG14-297-43aa,SNHG14-302-43aa,SNHG14-303-43aa,SNHG14-318-43aa-1,SNHG14-319-43aa-2,SNHG14-321-43aa,SNHG14-342-43aa-2)
Grand Average of Hydropathicity 0.2047
Relative Molecular Mass 5415.27
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000668419;SNHG14-315
Transcript Length 8232
Coding Ability 0.4425
DNA Sequence Corresponding to Peptide ATGCCTACCTGTGGTCTCTTGGACACCCTTGCAGATGACTTCCTGGGAACTCTTCTGGGAGTGAATGTTATCAGCAAATTCCCAAAACAACACCCCTTAGACAAAAAGCCTCCTCACCTATGCATTGCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :